Development of a synthetic diversification platform for targeted EVOLUTION of EN...
Development of a synthetic diversification platform for targeted EVOLUTION of ENZYMES supporting a sustainable bioeconomy – EvoZyme
The ongoing climate change requires immediate actions to reduce the CO2 concentration in the atmosphere. One such action is the transition from a fossil-based to a bio-based economy that builds on CO2-derived one-carbon (C1) feeds...
The ongoing climate change requires immediate actions to reduce the CO2 concentration in the atmosphere. One such action is the transition from a fossil-based to a bio-based economy that builds on CO2-derived one-carbon (C1) feedstocks like formate. To this end, synthetic C1 assimilation routes are being engineered into biotechnological relevant microbes. Among them, the reductive glycine pathway (rGlyP) bears enormous potential for biotechnological applications as it is short, energy efficient, and easy to engineer. So far, optimization of growth on formate via the rGlyP was achieved by adaptive laboratory evolution, a time-consuming process that leads to incorporation of undesired mutations and does not allow targeted pathway optimization (debottlenecking).
In EvoZyme, I aim to develop a Synthetic Biology platform for targeted evolution of pathway enzymes. This platform consists of specialized Escherichia coli strains that are equipped with state-of-the-art diversification machineries allowing tunable hyperdiversification/evolution of target enzymes. Furthermore, the platform is capable of transferring the diversified enzyme libraries to various bacterial hosts.
To benchmark the platform, I aim to debottleneck the rGlyP by targeting its core enzyme, the glycine cleavage system (GCS) which catalyzes the rate-limiting step of glycine synthesis. Diversification and optimization of the GCS will be tested in dedicated selection strains from different bacterial hosts that can only grow if a functional GCS is expressed. Ultimately, optimized GCS variants will be expressed in a formatotrophic E. coli strain lacking a GCS. Improved formatotrophic growth will be analyzed in lab-scale bioreactors to determine techno-economic parameters required for the establishment of a formate bioeconomy.
The platform developed in this project will enable debottlenecking of rate-limiting enzymes in virtually any pathway and presents a valuable tool for Synthetic Biology.ver más
15-11-2024:
PERTE CHIP IPCEI ME/...
Se ha cerrado la línea de ayuda pública: Ayudas para el impulso de la cadena de valor de la microelectrónica y de los semiconductores (ICV/ME)
15-11-2024:
REDES
En las últimas 48 horas el Organismo REDES ha otorgado 1579 concesiones
15-11-2024:
DGIPYME
En las últimas 48 horas el Organismo DGIPYME ha otorgado 3 concesiones
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.